Century Therapeutics (IPSC) Change in Account Payables (2020 - 2026)
Century Therapeutics (IPSC) reported Change in Account Payables of -$1.6 million for Q1 2026, down 550.14% year-over-year from $361000.0 in Q1 2025, and down 175.34% quarter-over-quarter from $2.2 million in Q4 2025.
Century Therapeutics (IPSC) Change in Account Payables (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Change in Account Payables data on file, last reported at -$1.6 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$1.6 million, down 550.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$424000.0 (up 76.41% YoY), and the FY2025 annual result was $1.6 million, up 206.33% from the prior year.
- Change in Account Payables fell to -$1.6 million in Q1 2026 per IPSC's latest filing, from $2.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $4.0 million in Q3 2023 and troughed at -$3.0 million in Q1 2023.
- A 5-year average of -$510647.1 and a median of -$591000.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2023 and 2026: Change in Account Payables jumped 465.72% in 2023, then slumped 550.14% in 2026.
- A 5-year view of Change in Account Payables shows it stood at -$1.6 million in 2022, then plunged by 76.79% to -$2.9 million in 2023, then jumped by 116.52% to $477000.0 in 2024, then soared by 352.2% to $2.2 million in 2025, then sank by 175.34% to -$1.6 million in 2026.
- Business Quant data shows IPSC's Change in Account Payables at -$1.6 million in Q1 2026, $2.2 million in Q4 2025, and -$591000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | -1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.63 Mn |
| Mar 31, 2026 | -1.63 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | -591,000.00 |
| Sep 30, 2025 | -591,000.00 |
| Jun 30, 2025 | -365,000.00 |
| Jun 30, 2025 | -365,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | -757,000.00 |
| Sep 30, 2024 | -757,000.00 |
| Jun 30, 2024 | -1.88 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | 689,000.00 |
| Mar 31, 2024 | 689,000.00 |
| Dec 31, 2023 | -2.89 Mn |
| Dec 31, 2023 | -2.89 Mn |